Huaren Pharmaceutical Co., Ltd.
Address: 187 Zhuzhou Road, Qingdao, Shandong Province, China
Post Code: 266100
Huaren Pharmaceutical Co., Ltd. (hereinafter referred to as “Huaren Pharmaceutical”) was established in May 1998 and completed its shareholding reform in August 2001. It is a holding company of Huaren Century Group. Its shareholders include Hongta Innovation Investment Co., Ltd., GF XINDE investment mamagement Co., Ltd., China Pharmaceutical University and other well-known domestic enterprises and universities. It is a new join-stock company integrating industry, university and research. Huaren Pharmaceutical has a registered capital of 436.627 million yuan, and currently employs nearly 3,000 people. Its total area is 262,000 square meters, including Qingdao plant 100,000 square meters, Rizhao plant 126,000 square meters, Pingdu plant 16,000 square meters and Jiaozhou plant 20,000 square meters. We continue to expand our production base. On November 26, 2013, Hubei Huaren Tongji Pharmaceutical Co., Ltd. was founded in Xiaogan City together with Wuhan Tongji Hospital. The foundation of phase I of this project was laid on December 20, 2013 and it is expected to go into production at the end of 2014. It will be engaged in the manufacturing of large volume injection and hospital preparations. Its full capacity is expected to generate sales volume approx 160 million yuan. Alliance between giants is expected in order to pay back to society via safe and quality infusion and medical products and all-sided customer services.
As a high-tech enterprise specializing in the production of Non-PVC soft bag infusion, Huaren Pharmaceutical has three categories of products: conventional infusion, therapy infusion and nutrition infusion, including 66 varieties and 135 specifications. Over the years, Huaren Pharmaceutical always has a high market reputation with stable and excellent products offered. Its products and services have been widely accepted and recognized by customers. It is among the top three leading players in the Non-PVC soft bag infusion sector. Peritoneal dialysis solution launched by Huaren Pharmaceutical is the first Non-PVC peritoneal dialysis solution brand in China. On December 9, 2013, the Company and JMS Corporation signed Patented and Proprietary Technology Licensing Contract, according to which, the two sides will manufacture and sell peritoneal dialysis solution products and related medical devices in China. In December 2013, the academician workstation project as lead by the Company was approved. Academician Chen Xiangmei is invited to lead a research team of nephrology specialists, all of whom have extensive experience in peritoneal dialysis clinical pharmacology and toxicology and will give technical guidance to the Company in the screening, pharmacology and independent research of peritoneal dialysis buffer salts and penetrant. In addition, they have better understandings on the demand of patients on peritoneal dialysis products since they have a direct contact with patients. Establishment of this station will sure facilitate development of new types of peritoneal dialysis products via industry-university-research cooperation, promote industrialization of research results as soon as possible, and help talent trainings.
Huaren Pharmaceutical goes forward regardless of hardship. In 1998, Huaren Pharmaceutical Co., Ltd. was founded. In 2001, it completed its shareholding reform. In August 2010, it was officially listed in Shenzhen GEM. In June 2011, it successfully launched peritoneal dialysis products. In 2012, it achieved "Medical Equipment Production License" and in 2013 obtained five medical device registration cards in succession, including "Disposable Incision Retractor". In 2013, the Company completed a wholly-owned acquisition of Shandong Jiejing Pharmaceutical Co., Ltd. and established Huaren Pharmaceutical (Rizhao) Co., Ltd, taking the first step in out-of-town operations. In April 2013, Huaren Pharmaceutical Blood Purification Products R&D Center was established. In May 2013, Huaren Pharmaceutical held its 15th anniversary celebration. In November 2013, Hubei Huaren Tongji Pharmaceutical Co., Ltd. was founded. In February 2014, Huaren Pharmaceutical established the first blood purification academician workstation in Shandong Province. Since then, it started its forward pace, facing China and going globally.
Huaren Pharmaceutical achieved overall local development in Qingdao, Jiaozhou and Pingdu and out-of-town operations in Rizhao and Wuhan. At present, it has 3 subsidiaries Huaren Pharmaceutical (Rizhao) Co., Ltd., Qingdao Huaren Medical product Co., Ltd. and Qingdao Huaren Medicinal Packing Material Sci-tech Co., Ltd. and 1 joint venture Hubei Huaren Tongji Pharmaceutical Co., Ltd.
“Benevolence” is the core of enterprise culture of Huaren Pharmaceutical. Much attention is devoted to management modes. Humane management is advocated. A “5TM” management mode comprising total quality management, total-staff performance management, total-course information management, total-course marketing management and total budget management is implemented. Management innovation, technological innovation, product innovation, quality innovation, marketing innovation and service innovation are advocated. “To better know about, employ, love, culture and respect people” employment philosophy is adhered to. Talent introduction, training and promotion mechanism is strengthened with a view to improving the capability of independent innovation and core competitiveness of company.
During the over ten years development, honorary title awarded to Huaren Pharmaceutical include "China Famous Brand", " Shandong Province Enterprise Observing Contract and Valuing Credit", "AAA Grade Credible Enterprise", "Shandong Province Enterprise of Outstanding Contributions during Eleventh Five-Year Plan", "Shandong Province Model Enterprise Fulfilling Social Commitments", "High-tech Enterprises", etc.
Huaren Pharmaceutical has always maintained a high growth rate. In particular, in the last three years sales revenues in 2011 and 2012 were 453.1 million yuan and 5.6203 million yuan, respectively, an increase of 38.67% year on year; and net profit 87.56 million yuan and 9659 million, respectively, an increase of 10.31% year on year. By the end of 2012, total assets of Huaren Pharmaceutical reached 1.785 billion yuan, an increase of 43.08% year on year. In 2013, the output value was 870 million yuan, an increase of 35%, sales income 900 million yuan, profit and tax 210 million yuan, an increase of 20% year on year.
Facing the future, we have made a five-year plan for R&D, production and sales of quality large-volume preparations and blood purification products of new medical treatment concepts on the basis of life science and clinical medicine supported by Non-PVC infusion packaging materials and advanced manufacturing technology. In 2015, the construction of a national level large-volume preparations research center will be completed and Huaren Pharmaceutical is expected to be one of the top 100 Chinese pharmaceutical companies and a leading player in the field of soft bag infusion, blood purification preparations, enteral and parenteral nutrition preparations.
As a listed company, Huaren Pharmaceutical is still in its rapid development stage. Facing the future, Huaren Pharmaceutical will actively set production and management objectives, advocate innovation and enhance core competitiveness by adjusting product structure, integrating human resources and improving production layout in order to become a modern enterprise with strong competition, high management efficiency, quick innovation and beautiful production environment.